2019 ABAI Continuous Assessment Program Literature Review Recordings– January-June Block
Update your knowledge of recent literature in allergy/immunology, and prepare for the ABAI’s Continuous Assessment Program (CAP) with this literature review course. Presenters provide a guided overview of the articles selected by the ABAI for the CAP for the January-June 2019 term. The four presentations cover a range of clinical conditions central to the specialty, including:
Immune Deficiency, Autoimmunity, and Immune-Based Disorders
Mast Cell Disorders, Eosinophilic Disorders, Anaphylaxis, and Drug-Insect-Vaccine Allergy
Food Allergy, Allergic and Immunologic Skin Disorders, and Urticaria-Angioedema
Head and Neck, and Lung
This activity includes recordings of the Literature Review Course offered in February 2019 at the AAAAI Annual Meeting in San Francisco.
Click the Program tab to access the full list of articles, with links. Please note that All CAP articles can also be accessed through the ABAI web portal.
Target Audience
- Allergist/Immunologists participating in continuous certification with the American Board of Allergy & Immunology
- Allied health providers working in allergy/immunology settings
- Allergy/Immunology Fellows-in-Training preparing for initial certification
- Other healthcare providers with an interest in allergy/immunology
Learning Objectives
Upon completion of this activity, participants should be able to discuss recently published research relevant to the practice of allergy/immunology.
ABAI CAP Reference List 1st Cycle 2018 (January – June)
All CAP articles are listed, below.
Articles can also be accessed through the ABAI web portal, and via the following PDF document:
ABAI 2018 CAP Reference List_1st Cycle January-June_AAAAI_FINAL.pdf
Section A. Hypersensitivity Disorders - (epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis and differential diagnosis, treatment/management)
A1 Head and Neck
- Li JT, et al. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report. J Allergy Clin Immunol. 2016 Feb;137(2):369-76. http://www.jacionline.org/article/S0091-6749(15)01031-3/pdf
- Bachert, C., L. Mannent, R.M. Naclerio, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis. J American Med Assoc. 2016;315(5):469-79. https://www.ncbi.nlm.nih.gov/pubmed/26836729
- Berard A, et al. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes, J Allergy Clin Immunol. 2016;138:97-104. http://www.jacionline.org/article/S0091-6749(16)00262-1/pdf
A2 Dermatologic
- T. Nomura and K. Kabashima. Advances in atopic dermatitis in 2015. J Allergy Clin Immunol 2016;138:1548-55. http://www.jacionline.org/article/S0091-6749(16)31210-6/pdf
- Fonacier, et al. Contact Dermatitis: A Practice Parameter-Update 2015. J Allergy Clin Immunol Pract. 2015;3:S1-S39 http://www.jaci-inpractice.org/article/S2213-2198(15)00116-6/pdf
- Simpson EL, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016 Dec 15;375(24):2335-2348. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1610020
A3 Lung
- Virchow JC, et al. Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults with Allergic Rhinitis. JAMA. 2016; 315(16): 1715-25. https://www.ncbi.nlm.nih.gov/pubmed/27115376
- Berry A, Busse W. Biomarkers in asthmatic patients: Has their time come to direct treatment? JACI. 2016:137:1317-24 https://www.ncbi.nlm.nih.gov/pubmed/27155028
- Bowatte G. Traffic-related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age. J Allergy Clin Immunol. 2017 Jan;139(1):122-129.e1. http://www.jacionline.org/article/S0091-6749(16)30357-8/pdf
A4 Food and Drug Allergy/Hypersensitivity Reactions
- Wood RA. Food allergen immunotherapy: Current status and prospects for the future. JACI. 2016;137:973.82. http://www.jacionline.org/article/S0091-6749(16)00086-5/pdf
- Perkin MR, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. N Engl J Med. 2016;374:1733-43. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1514210
- Togias A, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases sponsored expert panel. Ann Allergy Asthma Immunol. 118 (2017) 166e173. http://www.annallergy.org/article/S1081-1206(16)31164-4/pdf
A5 Anaphylaxis
- Golden, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. Xxx(2016): page 5 http://www.annallergy.org/article/S1081-1206(16)31270-4/abstract
- Lieberman P, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341-384. https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/2015-Anaphylaxis-PP-Update.pdf
- De Schryver S, et al. Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors. JACI. 2016;137:1138-42 http://www.jacionline.org/article/S0091-6749(15)01266-X/pdf
Section B. Immunological Disorders - (epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis and differential diagnosis, treatment/management)
B1 Immune Hypersensitivity Disorders
- Her M and Kavanaugh A. Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol. 2016;137:19-27. http://www.jacionline.org/article/S0091-6749(15)01580-8/pdf
- Green PHR, Lebwohl B, Greywoode R. Celiac Disease. JACI. Volume 135, Issue 5, Pages 1099–1106. http://www.jacionline.org/article/S0091-6749(15)00230-4/pdf
- Hoffman HM, Broderick L. The role of the inflammasome in patients with autoinflammatory diseases. JACI. 2016; 138:3-14 http://www.jacionline.org/article/S0091-6749(16)30283-4/pdf
B2 Immunodeficiencies
- Gudmundsdottir, Judith. Early thymectomy leads to premature immunologic ageing: An 18-year follow-up. JACI. November 2016 Volume 138, Issue 5, Pages 1439–1443.e10. http://www.jacionline.org/article/S0091-6749(16)30366-9/pdf
- Loffredo L, et al. Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections. Ann Allergy Asthma Immunol. 117(2016):285-289. http://dx.doi.org/10.1016/j.anai.2016.07.008
- Bonilla, FA. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78. http://www.jacionline.org/article/S0091-6749(15)00883-0/pdf
B3 Eosinophilic and Gastrointestinal Disorders
- Williams KW et al. Hypereosinophilia in Children and Adults: a retrospective comparison. JACI Practice. 2016; 4: 941-7. http://www.jaciinpractice.org/article/S2213-2198(16)30059-9/pdf
- Blumenthal KG, et al. Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. J Allergy Clin Immunol. 2015 Nov;136(5):1288-94. http://www.jacionline.org/article/S0091-6749(15)00541-2/pdf
- Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015 Oct 22;373(17):1640-8. http://www.nejm.org/doi/pdf/10.1056/NEJMra1502863
Planning Committee
David C. Chaplin, MD PhD FAAAAI
University of Alabama, Birmingham, AL
Relevant relationships: None
Leonard Bacharier, MD FAAAAI
Washington University, St. Louis, MO
Relevant relationships: DBV Technologies, Merck, Vectura (consultant); Boerhinger Ingelheim, Novartis, Circassia, GSK, Teva, Regeneron (advisory board); Novartis (speaker)
Faculty
Carla M. Davis, MD FAAAAI
Baylor College of Medicine, Houston, TX
Relevant relationships: None
John M. Kelso, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None
John Oppenheimer, MD FAAAAI
Pulmonary and Allergy Associates, Denville, NJ
Relevant relationships: None
John M. Routes, MD FAAAAI
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None
Reviewer
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Release date
Original release date: March 15, 2019. Valid for credit through December 31, 2019.
Questions
Activity-related questions should be directed to cme@aaaai.org
Available Credit
- 2.00 AttendanceAttendance credit.
- 2.00 CMECME credit.